Work Here?
Overview
EOS imaging makes imaging devices and software for orthopedics. Its EOS system provides low-dose, full-body 3D images in weight-bearing positions to measure skeletal alignment for diagnosis and surgical planning. The offering includes EOSedge and EOSapps, which enable safe imaging and specialized planning tools, and is supported by maintenance services. After its 2021 acquisition by Alphatec Holdings, the company aims to connect pre-operative imaging with intra-operative workflows to improve orthopedic outcomes and streamline the path from diagnosis to surgery.
About EOS imaging
Industries
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
IPO
Headquarters
Paris, France
Founded
1989
Get referred to EOS imaging
See people who can refer or advise you
Simplify's Take
What believers are saying
- ATEC 2025 revenue rose 25% to $764.2 million, funding EOS expansion.
- U.S. EOSedge installed base grew 39% year over year, driving EOS Insight adoption.
- ATEC launched 3D pediatric modeling and AutoDensity in 2025, broadening EOS use cases.
What critics are saying
- Q1 2026 EOS revenue fell to $14 million, missing ATEC’s quarterly goal.
- EOS relies on ATEC funding; persistent misses threaten sales hiring and product investment.
- A 2027 $100 million EOS target looks fragile; failure makes EOS a non-core asset.
What makes EOS imaging unique
- EOSedge captures standing full-body biplanar scans with no stitching or magnification.
- EOS Insight automates alignment measures and 3D pediatric modeling from one scan.
- ATEC embeds EOS imaging into spine workflow, linking planning, implants, and intraoperative execution.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$59.9M
Above
Industry Average
Funded Over
7 Rounds
Stock Price
Growth & Insights and Company News
6 month growth
↑ 2%1 year growth
↑ 1%2 year growth
↑ 1%Alphatechs USA is unveiling new Bluetooth school cafeteria pin pads and scanners at SNA ANC 2026 in Charlotte, North Carolina. The company will showcase Bluetooth versions of its AlphaPad pin pad and AlphaScan scanner combo at booth 1747. The new AlphaPad-BT and AlphaScan-BT feature Bluetooth 5.2 and are compatible with Windows, MacOS, iPads, iPhones, Android devices, Chromebooks and Microsoft Surface. According to founder and CEO Chris Fructus, the wireless versions provide greater flexibility for busy cafeteria environments. The Southern California-based company also offers USB versions and stand-alone barcode scanners. All devices are FCC-approved, assembled in the US, and come with a three-year warranty and price match guarantee. The products work with all US and Canadian school cafeteria point-of-sale software.
Western Standard disclosed in an SEC filing that it sold 1,232,881 shares of Alphatec Holdings during the first quarter, an estimated $17.95 million trade based on quarterly average pricing. Following the sale, Alphatec represents 0.13% of Western Standard's reported US equity assets. The disclosure came shortly before Alphatec reported disappointing first-quarter results. Revenue reached $192 million, up 14% year-over-year but missing analyst projections by approximately 4%. Surgical revenue climbed 17% and case volumes increased 21%, whilst adjusted EBITDA hit $21 million with expanding margins. However, the company lowered parts of its full-year outlook, triggering a more than 20% drop in after-hours trading to around $8.12. As of 4 May 2026, shares were priced at $10.33, down 13.8% over one year.
Alphatec Holdings, a Carlsbad, California-based medical equipment company, reported a first-quarter loss of $33.9 million, or 22 cents per share. Adjusted earnings came to less than one cent per share. The company posted revenue of $192.1 million, missing analyst expectations of $199.6 million from four analysts surveyed by Zacks. Alphatec expects full-year revenue of $882 million. Shares have fallen 51% since the beginning of the year. In Tuesday's trading, shares hit $10.23, down 15% over the past 12 months.
Alphatec Holdings, a medical technology company specialising in spinal disorder treatments, is amongst growth companies with high insider ownership in the United States. The company has a market capitalisation of $1.68 billion and generates revenue of $764.16 million from its medical products segment. The US market has risen 3.6% in the past week and 39% over the year, with earnings expected to grow 16% annually. Growth companies with high insider ownership are attracting attention as insider stakes often signal confidence from those closest to the business. Clearfield, another featured company, forecasts earnings growth of 61.1% annually, significantly outpacing the broader market. The company recently turned profitable and expects fiscal 2026 sales between $160 million and $170 million. Substantial insider buying occurred over the past three months.
Craig Hunsaker, executive vice president at Alphatec Holdings, sold 116,367 shares worth approximately $1.44 million, according to a SEC Form 4 filing. The sale represented 6.32% of his direct holdings, reducing his stake from 1.84 million to 1.73 million shares. The transaction exceeded Hunsaker's recent median sale of 80,438 shares but remained within his typical range of activity since April 2025. A portion of the sales (33,602 shares) were executed under a Rule 10b5-1 plan adopted in March 2025 for tax obligations related to vesting restricted stock units. Following the transaction, Hunsaker's remaining direct ownership is valued at approximately $22.21 million. Alphatec Holdings, which provides spinal surgery solutions, has a market capitalisation of $1.88 billion.
EOS imaging is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today
About EOS imaging
Industries
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
IPO
Headquarters
Paris, France
Founded
1989
EOS imaging is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today